What your patient needs to know about a non-specific symptom pathway referral for suspected cancer
British Journal of General Practice · 2024
DOI: 10.3399/bjgp24x737661 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of General Practice, 2024. Verfasst von Georgia Black und 1 weiteren Autor:innen. Beteiligte Einrichtung: Queen Mary University of London. Hauptthemen laut MEDLINE: Referral and Consultation, Neoplasms.
Abstract (Originalsprache)
Background
Non-specific symptom (NSS) pathways were implemented in the UK in 2017 to address the needs of patients experiencing symptoms such as weight loss, fatigue, or GP ‘gut feeling’.
Aim
To explore patients’ experiences of NSS pathways, and their potential support needs in terms of understanding and navigating these pathways.
Method
This study employed ethnographic methods across four NHS trusts in England, including interviews with 28 patients and 28 professionals, patient shadowing, and clinical care observations, to examine NSS pathways for cancer diagnosis. Analysis focused on patient communication and understanding of care.
Results
Patients found it hard to understand why they were referred. Only a minority of patients appreciated that multiple organs were being investigated for cancer. Progressing through the pathway was also difficult to understand, particularly around who was making decisions and what would happen next. Investigations often resulted in incidental findings. Patients whose persistent symptoms were not explained were often unsure what to do following discharge.
Conclusion
The findings resulted in recommended messages for GPs to support patients on referral to NSS pathways, including the nature of the pathway, the team that will be responsible for their care, the multiple organ systems that will potentially be investigated, and what will happen if they don’t find a cancer. Without this support, patients’ difficulties in comprehending previous investigations and findings could result in delays, overtesting, or inadequately targeted investigations, hindering the effective use of their medical history.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Queen Mary University of London.
- University of Oxford.
Zitieren
APA
Black, G., & Moreland, J. A. (2024). What your patient needs to know about a non-specific symptom pathway referral for suspected cancer. British Journal of General Practice. https://doi.org/10.3399/bjgp24x737661
Vancouver
Black G, Moreland JA. What your patient needs to know about a non-specific symptom pathway referral for suspected cancer. British Journal of General Practice. 2024. doi:10.3399/bjgp24x737661
BibTeX
@article{Black2024,
author = {Black, Georgia and Moreland, Julie-Ann},
title = {What your patient needs to know about a non-specific symptom pathway referral for suspected cancer},
journal = {British Journal of General Practice},
year = {2024},
doi = {10.3399/bjgp24x737661}
}
EUVIMED